Ashton Tweed Connection Vol. 4 No. 5

Share

ASHTON TWEED CONNECTION

VOL. 4 NO. 5

Featuring CEO Interview with James Caruso, President & CEO, Cellectar Biosciences

 
Your Issue of Ashton Tweed Connection Vol. 4 No. 5 is Here!
Ashton Tweed Homepage
Our Site
View Ashton Tweed Connection in Browser
Vol. 4
No. 5
Ashton Tweed can meet your specialized retained search & interim talent needs in the life sciences industry.
   CEO Leadership Series: James Caruso, President & CEO, Cellectar Biosciences
CEO Leadership Series: James Caruso, President & CEO, Cellectar Biosciences
In his 27 years as a biotech and pharmaceutical professional, James Caruso has held key executive positions at organizations of all sizes, from Big Pharma to small specialty companies to a startup. One constant throughout his career...
Read More
   Blog: 5 Reasons it's More Than Just a Thank-You Email
Blog: 5 Reasons it's More Than a Thank-You Email
That's right, not a text, but a thank you email! Whether it's after an interview, a networking event, or a business lunch, it all matters! Most of us have been encouraged to send thank you emails promptly after professional interactions...
Read More Blog: 5 Reasons it's More Than Just a Thank-You Email
  Blog: Top 5 Podcasts for Life Science Execs
Blog: Top 5 Podcasts for Life Science Execs
Have some free time while traveling, commuting, or working out? Put it to good use! Podcasts are a great way to make the most of your down time by getting your gears turning and keeping you up-to-date with the latest industry news and...
Read More Blog: Top 5 Podcasts for Life Science Execs
Subscribe Now!
Don't miss out on top hiring news!
Ashton Tweed's Weekly Digest email covers hiring, firing, & retiring news in the life sciences. Also, check out our:
Featured Candidates Featured Candidates
Upcoming Events Upcoming Events
Recent Editions Recent Editions
point
  Life Sciences Professionals Name Top 30 Ideal Employers
Life Sciences Professionals Name Top 30 Ideal Employers
According to the 2017 Life Sciences Ideal Employer Report, the top three most important attributes are the opportunity to do interesting and meaningful work, a competitive salary and a good reputation. BioSpace surveyed more than 2,400...
Read More Life Sciences Professionals Name Top 30 Ideal Employers
  FDA’s Generic Drugs Office Passes Last Year’s Record for ANDAs Received
FDA Passes Last Year's Record for ANDAs Received
Two-thirds of the way through fiscal year 2017, the FDA has received at least 877 ANDAs, passing 2016's total of 852 and beating 2015 by more than 330 applications. So far, the agency has totaled 477 approvals for 2017, 119 of ...
Read More FDA’s Generic Drugs Office Passes Last Year’s Record for ANDAs Received
  EpiPen alternative Symjepi gets FDA OK
EpiPen alternative Symjepi gets FDA OK
The FDA has approved a new allergic reaction medication that could provide an alternative to Mylan's EpiPen. Adamis Pharmaceuticals' Symjepi comes as two pre-filled syringes of epinepherine and is indicated for...
Read More EpiPen alternative Symjepi gets FDA OK
  J&J, Pfizer, Merck sit atop Fortune's 500 for pharma
J&J, Pfizer, Merck sit atop Fortune's 500 for pharma
J&J, Pfizer and Merck top Fortune's 500 for the pharma industry, but large drug wholesalers and pharmacy benefit managers beat them easily. In 2017's Fortune 500 list, which identifies companies that have generated...
Read More J&J, Pfizer, Merck sit atop Fortune's 500 for pharma
Featured Event: MedCity CONVERGE
When: July 31-August 1, 2017 Where: Philadelphia, PA This event is a two-day executive summit that gathers all sectors of healthcare to provide the most accurate picture of the future of healthcare innovation...
Read More
   Featured Event: MedCity CONVERGE
Supreme Court ruling gives biosimilars a boost
Biosimilar makers could get drugs to market more quickly following a recent ruling from the Supreme Court. In a unanimous opinion, the Supreme Court ruled that biosimilar drug developers won't have to wait for FDA approval...
Read More Supreme Court ruling gives biosimilar makers a boost
Launching the Biden Cancer Initiative
Vice President Joe Biden and Dr. Jill Biden launched the Biden Cancer Initiative, their new venture to accelerate progress in cancer prevention, detection, diagnosis, research and care, and to reduce...
Read More Launching the Biden Cancer Initiative
About Ashton Tweed, Ltd.
At the very core of Ashton Tweed's talent-acquisition and talent-placement business is a robust professional force of highly experienced life sciences industry experts. These uniquely talented professionals are deployed throughout Ashton Tweed’s diverse range of service offerings to solve our clients’ human capital and management needs.
Ashton Tweed on Twitter Ashton Tweed on Facebook Ashton Tweed on Google+ Ashton Tweed on LinkedIn
Contact Ashton Tweed
©2017 Ashton Tweed. All rights reserved.
Share

Leave a Reply

Your email address will not be published. Required fields are marked *